MCID: HMF004
MIFTS: 39

Hemifacial Spasm malady

Categories: Genetic diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Hemifacial Spasm

About this section

Aliases & Descriptions for Hemifacial Spasm:

Name: Hemifacial Spasm 49 27

Classifications:



Summaries for Hemifacial Spasm

About this section
NINDS:49 Hemifacial spasm is a neuromuscular disorder characterized by frequent involuntary contractions (spasms) of the muscles on one side (hemi-) of the face (facial). The disorder occurs in both men and women, although it more frequently affects middle-aged or elderly women. It is much more common in the Asian population.  The first symptom is usually an intermittent twitching of the eyelid muscle that can lead to forced closure of the eye. The spasm may then gradually spread to involve the muscles of the lower face, which may cause the mouth to be pulled to one side. Eventually the spasms involve all of the muscles on one side of the face almost continuously. The condition may be caused by a facial nerve injury, or a tumor, or it may have no apparent cause. Rarely, doctors see individuals with spasm on both sides of the face.  Most often hemifacial spasm is caused by a blood vessel pressing on the facial nerve at the place where it exits the brainstem.

MalaCards based summary: Hemifacial Spasm is related to focal dystonia and hemifacial spasm, familial. An important gene associated with Hemifacial Spasm is FLT4 (Fms Related Tyrosine Kinase 4), and among its related pathways are VEGF binds to VEGFR leading to receptor dimerization and Angiogenesis (CST). Affiliated tissues include eye, brain and bone, and related mouse phenotype reproductive system.

Wikipedia:71 Hemifacial spasm (HFS) is a rare neuromuscular disease characterized by irregular, involuntary muscle... more...

Related Diseases for Hemifacial Spasm

About this section

Diseases in the Hemifacial Spasm family:

Hemifacial Spasm, Familial

Diseases related to Hemifacial Spasm via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 115)
idRelated DiseaseScoreTop Affiliating Genes
1focal dystonia30.2NOS3, VEGFA
2hemifacial spasm, familial12.4
3epidermoid brain tumor10.9
4blepharospasm10.6
5trigeminal neuralgia10.4
6dystonia10.3
7aneurysm10.3
8glossopharyngeal neuralgia10.2
9vesiculobullous skin disease10.1FLT4, VEGFA
10factitious disorder10.1FLT4, VEGFA
11renal adenoma10.1FLT4, VEGFA
12benign familial neonatal epilepsy10.1FLT4, VEGFA
13mitral valve stenosis10.1FLT4, VEGFA
14cryptosporidiosis10.1MTHFR, VEGFA
15angular blepharoconjunctivitis10.1MTHFR, VEGFA
16metagonimiasis10.1FLT4, VEGFA
17human granulocytic anaplasmosis10.1FLT4, VEGFA
18scar contracture10.1MTHFR, VEGFA
19kartagener syndrome10.1MTHFR, NOS3
20common variable immunodeficiency10.1NOS3, VEGFA
21ectodermal dysplasia 9, hair/nail type10.1NOS3, VEGFA
22glutathionuria10.1MTHFR, NOS3
23lipoma10.1
24cervical dystonia10.1
25cervicitis10.1
26pancreas adenocarcinoma10.1MTHFR, VEGFA
27pyriform sinus cancer10.1NOS3, VEGFA
28villous adenoma10.1MTHFR, NOS3
29vernal conjunctivitis10.1MTHFR, VEGFA
30alpha-2-plasmin inhibitor deficiency10.1MTHFR, NOS3
31zellweger syndrome10.1NOS3, VEGFA
32neuropathy, hereditary sensory, type ib10.0MTHFR, VEGFA
33acute posterior multifocal placoid pigment epitheliopathy10.0NOS3, VEGFA
34contagious pustular dermatitis10.0MTHFR, VEGFA
35oppositional defiant disorder10.0NOS3, VEGFA
36astrocytoma10.0
37fiedler's myocarditis10.0NOS3, VEGFA
38neurofibroma of the heart10.0MTHFR, NOS3
39citrullinemia, type ii, neonatal-onset10.0NOS3, VEGFA
40hemolytic anemia10.0FLT4, VEGFA
41obstructive jaundice10.0MTHFR, VEGFA
42vaginal endometrial stromal sarcoma10.0TYMS, VEGFA
43human venous malformation10.0NOS3, VEGFA
44non-distal monosomy 10q10.0MTHFR, VEGFA
45arachnoiditis10.0
46bell's palsy10.0
47cerebellopontine angle tumor10.0
48meige syndrome10.0
49intracranial hypertension10.0
50arachnoid cysts10.0

Graphical network of the top 20 diseases related to Hemifacial Spasm:



Diseases related to hemifacial spasm

Symptoms & Phenotypes for Hemifacial Spasm

About this section

MGI Mouse Phenotypes related to Hemifacial Spasm according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053898.4FLT4, MTHFR, NOS3, VEGFA

Drugs & Therapeutics for Hemifacial Spasm

About this section

Drugs for Hemifacial Spasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 34)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
AcetylcholineapprovedPhase 4, Phase 3, Phase 280551-84-3187
Synonyms:
ACh
Acetyl choline ion
Acetylcholine Chloride
Acetylcholine cation
 
Acetylcholinium: acetyl-Choline
Choline acetate
Choline acetate (ester)
O-Acetylcholine
acetylcholine chloride
2Neurotransmitter AgentsPhase 4, Phase 3, Phase 218340
3abobotulinumtoxinAPhase 4, Phase 3, Phase 2652
4incobotulinumtoxinAPhase 4, Phase 3, Phase 2662
5onabotulinumtoxinAPhase 4, Phase 3, Phase 2652
6Cholinergic AgentsPhase 4, Phase 3, Phase 23992
7Botulinum Toxins, Type APhase 4, Phase 3, Phase 2657
8Peripheral Nervous System AgentsPhase 3, Phase 223689
9Neuromuscular AgentsPhase 3, Phase 21180
10Botulinum ToxinsPhase 3, Phase 2697
11
Isofluraneapproved, vet_approved17126675-46-73763
Synonyms:
1-Chloro-2,2,2-trifluoroethyl difluoromethyl ether
1-chloro-2,2,2-Trifluoroethyl difluoromethyl ether
2-Chloro-2-(difluoromethoxy)-1,1,1-trifluoroethane
2-chloro-2-difluoromethoxy-1,1,1-trifluoroethane
26675-46-7
AC-154802
AC1L1GNN
AErrane (Veterinary)
Aerrane
BRN 1852087
C07518
CCRIS 3043
CHEBI:6015
CHEMBL1256
CID3763
Compound 469
D00545
D007530
DB00753
EINECS 247-897-7
Ethane
Ether, 1-chloro-2,2,2-trifluoroethyl difluoromethyl
 
Forane
Forane (TN)
Forene
I14-1303
IsoFlo
Isoflurane
Isoflurane (JP15/USP/INN)
Isoflurane [Anaesthetics, volatile]
Isoflurane [USAN:BAN:INN:JAN]
Isoflurane [USAN:INN:BAN:JAN]
Isoflurane [Usan:Ban:Inn:Jan]
Isoflurano
Isoflurano [INN-Spanish]
Isofluranum
Isofluranum [INN-Latin]
Jsp005223
LS-7462
MolPort-000-153-606
NCGC00181037-01
R-E 235dal
ST51041445
UNII-CYS9AKD70P
isoflurane
12
Zincapproved22967440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
13
Desfluraneapproved15057041-67-542113
Synonyms:
(+-)-2-Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
1,1,1,2-Tetrafluoro-2-(difluoromethoxy)ethane
1,1,1,2-tetrafluoro-2-(difluoromethoxy)ethane
2-(difluoromethoxy)-1,1,1,2-tetrafluoroethane
57041-67-5
AC1L274J
AC1Q4ICY
C07519
C3H2F6O
CHEBI:4445
CHEMBL1200733
CID42113
D00546
DB01189
DESFLURANE
Desflurane
 
Desflurane (JAN/USP/INN)
Desflurane [USAN:INN]
Desflurano
Desflurano [INN-Spanish]
Desfluranum
Desfluranum [INN-Latin]
Difluoromethyl 1,2,2,2-tetrafluoroethyl ether
I 653
I-653
I653
LS-65505
MolPort-001-776-387
PC6781E
Suprane
Suprane (TN)
UNII-CRS35BZ94Q
difluoromethyl 1,2,2,2-tetrafluoroethyl ether
r-e 236ea1
14
Propofolapproved, investigational, vet_approved10822078-54-84943
Synonyms:
2, 6-Diisopropylphenol
2,6 Diisopropylphenol
2,6-Bis(1-methylethyl)phenol
2,6-Bis(Isopropyl)-phenol
2,6-DIISOPROPYLPHENOL
2,6-Diisopropyl phenol
2,6-Diisopropylphenol
2,6-bis(1-methylethyl)-phenol
2,6-di(propan-2-yl)phenol
2078-54-8
28449-97-0
4-06-00-03435 (Beilstein Handbook Reference)
50356-15-5
AB00513968
AC-2038
AC1L1J9Y
AC1Q1OUI
AI3-26295
AM-149
Abbott Brand of Propofol
Alpha Brand of Propofol
Ampofol
Aquafol
Astra Brand of Propofol
AstraZeneca Brand of Propofol
BIDD:GT0436
BPBio1_000950
BPBio1_000969
BRD-K82255054-001-03-5
BRN 1866484
BSPBio_000862
Biomol-NT_000248
Braun Brand of Propofol
C07523
C12H18O
CAS-2078-54-8
CCRIS 9000
CHEBI:44915
CHEMBL526
CID4943
CPD-11437
CPD000059151
Curamed Brand of Propofol
D00549
D015742
D0617
D126608
D126608_ALDRICH
DB00818
DDS-04F
Diisopropylphenol
Dipravan
Diprivan
Diprivan (TN)
Diprivan Injectable emulsion
Disoprivan
Disoprofol
EINECS 218-206-6
EU-0100437
Fresenius Brand of Propofol
Fresenius Kabi Brand of Propofol
Fresofol
HMS1570L04
HMS2089O21
HMS2094E17
 
HSDB 7123
ICI 35,868
ICI 35868
ICI-35,868
ICI-35868
ICI35,868
ICI35868
InChI=1/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H
Ivofol
Jsp004266
Juste Brand of Propofol
LS-996
Lopac-D126608
Lopac0_000437
MLS001066348
MLS001335999
MLS002454360
MolPort-001-794-517
NCGC00015389-01
NCGC00015389-02
NCGC00015389-04
NCGC00015389-09
NCGC00091538-01
NCGC00091538-02
NCGC00091538-03
NCGC00091538-04
NCGC00091538-05
NCGC00091538-06
NSC 5105
NSC5105
PFL
Parnell Brand of Propofol
Pisa Brand of Propofol
Prestwick0_000931
Prestwick1_000931
Prestwick2_000931
Prestwick3_000931
Propofol
Propofol (JAN/USAN/INN)
Propofol Abbott
Propofol Fresenius
Propofol IDD-D
Propofol MCT
Propofol Rovi
Propofol [USAN:INN:BAN]
Propofol(2,6-Diisopropylphenol)
Propofol-Lipuro
Propofolum
Propofolum [Latin]
Rapinovet
Recofol
Rovi Brand of Propofol
S01-0189
SAM002264610
SMR000059151
SPBio_003031
SPECTRUM1505022
ST50405911
Schering Brand of Propofol
UNII-YI7VU623SF
W505102_ALDRICH
ZD-0859
ZINC00968303
Zeneca Brand of Propofol
ghl.PD_Mitscher_leg0.558
nchembio.552-comp7
propofol
15
Benzocaineapproved20161994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthone
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Bensokain
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Caswell No. 430A
Chloraseptic
D001566
D00552
DB01086
Dermoplast
Diet Ayds
DivK1c_000932
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
 
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Formate, Benzocaine
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Hurricaine
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Keloform
LS-35847
MLS001331704
MLS002153970
Methanesulfonate, Benzocaine
MolPort-000-871-526
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Norcain
Norcaine
Norcainum
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orthesin
Otocain
Outgro
Parathesin
Parathesin (TN)
Parathesine
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Topcaine
UNII-U3RSY48JW5
WLN: ZR DVO2
ZINC12358719
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
16
Sevofluraneapproved, vet_approved50828523-86-65206
Synonyms:
1,1,1,3,3,3-Hexafluoro-2-(fluoromethoxy)propane
28523-86-6
AC-15484
AC1L1JU0
BRN 2041023
Bax 3084
C009250
C07520
C4H3F7O
CHEBI:9130
CHEMBL1200694
CID5206
D00547
DB01236
F0691
Fluoromethyl 1,1,1,3,3,3-Hexafluoroisopropyl Ether
Fluoromethyl 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
I14-13357
LS-67851
MR6S4
 
MR_6S4
MolPort-001-775-746
NCGC00167421-01
PC4681
Sevofluran
Sevoflurane
Sevoflurane (JAN/USAN/INN)
Sevoflurane [USAN:INN:BAN:JAN]
Sevoflurano
Sevoflurano [INN-Spanish]
Sevofluranum
Sevofluranum [INN-Latin]
Sevofrane
Sevorane
Sojourn
UNII-38LVP0K73A
Ultane
Ultane (TN)
ZINC01530810
fluoromethyl hexafluoroisopropyl ether
fluoromethyl-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ether
sevoflurane
17
Glucosamineapproved, Nutraceutical1913416-24-8439213
Synonyms:
(+)-2-amino-2-deoxy-D-glucopyranose
(2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(2S,5R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
(3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)oxane-2,4,5-triol
14257-69-3
2-Amino-2-deoxy-D-Glucose
2-Amino-2-deoxy-D-glucopyranose
2-Amino-2-deoxy-D-glucose
2-Amino-2-deoxy-beta-D-glucopyranose
2-Amino-2-deoxyglucose
2-Aminoglucose
2-Deoxy-2-amino-D-glucose
2-Deoxy-2-aminoglucose
2-amino-2-deoxy-D-glucopyranose
2-amino-2-deoxyglucose
2351-15-7
28905-10-4
2B4D44B2-D5AC-4DA4-9BE6-A4AE9574E4A6
3416-24-8
4-04-00-02017 (Beilstein Handbook Reference)
58-87-7
58267-75-7
6490-70-6
880765-44-6
90-77-7
911653-84-4
AC1L2D1C
AC1L96WB
AC1L9B8P
AC1Q4UBH
BRN 1724602
BSPBio_002086
C00329
C08349
CHEBI:28393
CHEBI:47977
CHEMBL234432
CID18897
CID439213
CID441477
CPD0-1193
Chitosamine
Cosamin
D-(+)-Glucosamine
 
D-Glucosamine
D-glucosamine
D04334
DB01296
DivK1c_000261
EINECS 222-311-2
GCS
Glucosamina
Glucosamina [INN-Spanish]
Glucosamine (USAN/INN)
Glucosamine [USAN:INN]
Glucosaminum
Glucosaminum [INN-Latin]
HMS500N03
HSDB 7469
IDI1_000261
InChI=1/C6H13NO5/c7-3-5(10)4(9)2(1-8)12-6(3)11/h2-6,8-11H,1,7H2/t2-,3-,4-,5-,6-/m1/s1
KBio1_000261
KBio2_001311
KBio2_003879
KBio2_006447
KBio3_001306
KBioGR_000970
KBioSS_001311
LS-71671
MolPort-002-507-091
MolPort-003-944-937
NCGC00164421-01
NCGC00178826-01
NINDS_000261
SPBio_000477
STK801823
Spectrum2_000519
Spectrum3_000443
Spectrum4_000565
Spectrum5_000756
Spectrum_000831
Viartril-S
beta-D-Glucosamine
bmse000247
chitosamine
glucosamine
nchembio.189-comp4
nchembio.2007.41-comp7
nchembio.412-comp5
partially N-deacetylated poly-beta-1,6-N-acetyl-D-glucosamine
18tannic acidapproved, Nutraceutical2016
19Micronutrients6001
20Lipid Regulating Agents2766
21Anesthetics9596
22Central Nervous System Depressants13403
23Trace Elements6001
24Hypolipidemic Agents2785
25Anticoagulants2623
26Anesthetics, General2934
27Hypoglycemic Agents5896
28Antimetabolites12054
29Fibrinolytic Agents2388
30Anesthetics, Inhalation684
31Glucuronyl glucosamine glycan sulfate140
32Anesthetics, Local3492
33Zinc SupplementNutraceutical32
34
Methylcobalaminexperimental, NutraceuticalEarly Phase 126013422-55-4
Synonyms:
Algobaz
Co-Methylcobalamin
Co-methylcobalamin
Hitocobamin M
MeCbl
Mecobalamin
Methycobal
 
Methyl cobalamine
Methyl vitamin B12
Methyl-5,6-dimethylbenzimidazolylcobalamin
Methyl-B12
Methylcob(III)alamin
Methylcobalamin
Methylcobaz
mecobalamin
methyl(III)cobalamin

Interventional clinical trials:

(show all 16)
idNameStatusNCT IDPhase
1Post Marketing Surveillance Study of DysportCompletedNCT00210431Phase 4
2Assessment of Effectiveness and Safety of Dysport® for the Treatment of Hemifacial SpasmCompletedNCT00276315Phase 3
3Effect on Tear Functions of Pretarsal and Preseptal Techniques of Botulinum Toxin Type A Injection in Hemifacial SpasmUnknown statusNCT01564979Phase 2
4Hemifacial Spasm and DesfluraneUnknown statusNCT01726725
5Observe Abnormal Potential From the Offending Vessel to the Facial Muscles of HFS PatientsUnknown statusNCT01271634
6Testing the Effect of Zinc Supplementation to Improve the Treatment Effect of Botulinum Toxin for Oculofacial SpasmUnknown statusNCT01546805
7A Multicenter, Observational Study to Evaluate Clinical Manifestation, Diagnosis and Treatment of Primary Hemifacial Spasm in Chinese PatientsCompletedNCT01728428
8Movement Disorder Survey in East ChinaCompletedNCT01168388
9Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression SurgeryCompletedNCT01613781
10Determination of Target of Adequate Partial Neuromuscular Blockade for Electrophysiologic Monitoring During Microvascular Decompression SurgeryCompletedNCT01598961
11Effect of Acupuncture on Inflammation and Immune Function After CraniotomyRecruitingNCT02761096
12Blepharospasm ToolsRecruitingNCT02780336
13An RCT of a Patient-initiated Treatment Service for BEB and HFSActive, not recruitingNCT02577224
14Autologous Adipose Mesenchymal Stem Cell Transplantation in the Treatment of Patients With Hemifacial SpasmNot yet recruitingNCT02853942Early Phase 1
15Diagnostic Test of Choice for HELPS SyndromeNot yet recruitingNCT03126955
16CSF Leak Following Microvascular Decompression: the Benefit of Routine Postoperative Lumbar TapWithdrawnNCT01932255

Search NIH Clinical Center for Hemifacial Spasm

Genetic Tests for Hemifacial Spasm

About this section

Genetic tests related to Hemifacial Spasm:

id Genetic test Affiliating Genes
1 Hemifacial Spasm27

Anatomical Context for Hemifacial Spasm

About this section

MalaCards organs/tissues related to Hemifacial Spasm:

36
Eye, Brain, Bone, Caudate nucleus, Thalamus

Publications for Hemifacial Spasm

About this section

Articles related to Hemifacial Spasm:

(show top 50)    (show all 630)
idTitleAuthorsYear
1
Hemifacial Spasm Secondary to Parotid Pleomorphic Adenoma With Stylomastoid Foramen Extension. (27755360)
2017
2
Analysis of facial motor evoked potentials for assessing a central mechanism in hemifacial spasm. (27177175)
2016
3
Hemifacial spasm associated with type 1 Chiari malformation: a retrospective study of 13 cases. (27422274)
2016
4
Facial spasms, but not hemifacial spasm: a case report and review of literature. (26984806)
2016
5
Ephaptic transmission is the origin of the abnormal muscle response seen in hemifacial spasm. (27072096)
2016
6
Erratum to: 'Effectiveness and cost-effectiveness of a patient-initiated botulinum toxin treatment model for blepharospasm and hemifacial spasm compared to standard care: study protocol for a randomised controlled trial'. (27439615)
2016
7
The value of lateral spread response monitoring in predicting the clinical outcome after microvascular decompression in hemifacial spasm: a prospective study on 100 patients. (27053220)
2016
8
Imaging of Neurovascular Compression Syndromes: Trigeminal Neuralgia, Hemifacial Spasm, Vestibular Paroxysmia, and Glossopharyngeal Neuralgia. (26892985)
2016
9
Five-Year Retrospective Review of Cases with Benign Essential Blepharospasm and Hemifacial Spasm Presenting in a Tertiary Eye Care Center in North India. (27078720)
2016
10
A Rare Cause of Hemifacial Spasm: Papillary Oncocytic Cystadenoma. (27761290)
2016
11
A significant correlation between delayed cure after microvascular decompression and positive response to preoperative anticonvulsant therapy in patients with hemifacial spasm. (27235129)
2016
12
Vagoglossopharyngeal Neuralgia Occurred Concomitantly with Ipsilateral Hemifacial Spasm and Versive Seizure-Like Movement: A First Case Report. (27455832)
2016
13
Outcome of microvascular decompression for hemifacial spasm associated with the vertebral artery. (27278791)
2016
14
Botulinum Toxin Treatment of Blepharospasm, Orofacial/Oromandibular Dystonia, and Hemifacial Spasm. (26866500)
2016
15
Coexistence of ocular neuromyotonia and hemifacial spasm. (26810424)
2016
16
Sexual Well-Being in Patients with Blepharospasm, Spasmodic Torticollis, and Hemifacial Spasm: A Pilot Study. (27761118)
2016
17
Application of electrophysiological methodsA and magnetic resonance tomographic angiography in the differentiation between hemifacial spasm and Meige syndrome. (26838523)
2016
18
Delayed Facial Palsy After Microvascular Decompression for Hemifacial Spasm. (27046467)
2016
19
Prognostic ability of intraoperative electromyographic monitoring during microvascular decompression for hemifacial spasm to predict lateral spread response outcome. (27104851)
2016
20
Comparison of brain MRI angiography and brain MRI cisternography in patients with hemifacial spasm. (26908032)
2016
21
Significance of anomalous anterior inferior cerebellar artery-posterior inferior cerebellar artery common trunk compression in microvascular decompression for hemifacial spasm. (27155382)
2016
22
Bioglue-Coated Teflon Sling Technique in Microvascular Decompression for Hemifacial Spasm Involving the Vertebral Artery. (27651870)
2016
23
Is hypertension a risk factor of hemifacial spasm? (26969561)
2016
24
Alleviating Maneuvers for Benign Essential Blepharospasm and Hemifacial Spasm. (27607413)
2016
25
Preoperative three-dimensional diagnosis of neurovascular relationships at the root exit zones during microvascular decompression for hemifacial spasm. (27178237)
2016
26
Effectiveness and cost-effectiveness of a patient-initiated botulinum toxin treatment model for blepharospasm and hemifacial spasm compared to standard care: study protocol for a randomised controlled trial. (26961367)
2016
27
Increasing the area and varying the dosage of Botulinum toxin a injections for effective treatment of hemifacial spasm. (27067535)
2016
28
Hemifacial Spasm Associated with Contralateral Foramen Magnum Meningioma. (26826538)
2016
29
Brainstem Developmental Venous Anomaly Causing Hemifacial Spasm - Case Report and Review of the Literature. (27133013)
2016
30
Reply to "The origin of the abnormal muscle response seen in hemifacial spasm remains controversial". (27189845)
2016
31
Long-term surgical results in microvascular decompression for hemifacial spasm: efficacy, morbidity and quality of life. (27214834)
2016
32
Vascular tortuosity in relationship with hypertension and posterior fossa volume in hemifacial spasm. (27473840)
2016
33
The origin of the abnormal muscle response seen in hemifacial spasm remains controversial. (27222310)
2016
34
Tentorial meningioma presenting as hemifacial spasm: An unusual clinical scenario. (27057238)
2016
35
Good surgical outcomes of hemifacial spasm patients with obvious facial nerve indentation and color change. (27184901)
2016
36
The association between vertebrobasilar dolichoectasia and hemifacial spasm. (27567723)
2016
37
Endoscopic Microvascular Decompression with Transposition for Trigeminal Neuralgia and Hemifacial Spasm: Technical Note. (27595274)
2016
38
Flatness of the infratentorial space associated with hemifacial spasm. (27179978)
2016
39
Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment. (27431279)
2016
40
Benefits of microvascular decompression on social anxiety disorder and health-related quality of life in patients with hemifacial spasm. (27155866)
2016
41
Teflon Might Be a Factor Accounting for a Failed Microvascular Decompression in Hemifacial Spasm: A Technical Note. (27251374)
2016
42
Efficacy of levetiracetam in primary hemifacial spasm. (27460515)
2016
43
Placement of Teflon Sponges in Microvascular Decompression Procedure for Treatment of Hemifacial Spasm. (25798798)
2015
44
Preoperative Evaluation of Patients with Hemifacial Spasm by Three-dimensional Time-of-Flight (3D-TOF) and Three-dimensional Constructive Interference in Steady State (3D-CISS) Sequence. (25795466)
2015
45
Systematic Literature Review of AbobotulinumtoxinA in Clinical Trials for Blepharospasm and Hemifacial Spasm. (26566457)
2015
46
Cerebellar retraction and hearing loss after microvascular decompression for hemifacial spasm. (25514867)
2015
47
Subjective and Objective Measures in the Treatment of Hemifacial Spasm With OnabotulinumtoxinA. (25811161)
2015
48
Clinical and electrophysiological studies of botulinum toxin type A to treat hemifacial spasm complicated with auricular symptoms. (26309655)
2015
49
Microvascular decompression under neuroendoscopic view in hemifacial spasm: rostral-type compression and perforator-type compression. (25502988)
2015
50
CPAP Therapy Improves Intractable Hemifacial Spasm. (26550503)
2015

Variations for Hemifacial Spasm

About this section

Expression for genes affiliated with Hemifacial Spasm

About this section
Search GEO for disease gene expression data for Hemifacial Spasm.

Pathways for genes affiliated with Hemifacial Spasm

About this section

GO Terms for genes affiliated with Hemifacial Spasm

About this section

Biological processes related to Hemifacial Spasm according to GeneCards Suite gene sharing:

(show all 11)
idNameGO IDScoreTop Affiliating Genes
1cellular response to vascular endothelial growth factor stimulusGO:003592410.1FLT4, VEGFA
2positive regulation of endothelial cell migrationGO:001059510.1FLT4, VEGFA
3positive regulation of endothelial cell proliferationGO:000193810.0FLT4, VEGFA
4positive regulation of protein kinase C signalingGO:009003710.0FLT4, VEGFA
5lung developmentGO:003032410.0NOS3, VEGFA
6positive regulation of angiogenesisGO:00457669.9NOS3, VEGFA
7response to folic acidGO:00515939.7MTHFR, TYMS
8tetrahydrofolate interconversionGO:00359999.6MTHFR, TYMS
9tetrahydrofolate metabolic processGO:00466539.6MTHFR, TYMS
10angiogenesisGO:00015259.5FLT4, NOS3, VEGFA
11vascular endothelial growth factor receptor signaling pathwayGO:00480109.5FLT4, VEGFA

Molecular functions related to Hemifacial Spasm according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1flavin adenine dinucleotide bindingGO:00506609.7MTHFR, NOS3
2NADP bindingGO:00506619.3MTHFR, NOS3

Sources for Hemifacial Spasm

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet